NDRA logo

ENDRA Life Sciences (NDRA) Company Overview

Profile

Full Name:

ENDRA Life Sciences Inc.

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

June 30, 2017

Indexes:

Not included

Website:

http://endrainc.com

Description:

NDRA, part of ENDRA Life Sciences, focuses on developing innovative imaging technology for medical applications. Their main product, the ThermoScientific, provides advanced thermal imaging to improve disease detection and monitoring, enhancing patient care and outcomes in various healthcare settings.

Key Details

Price

$4.32

Market Cap

$2.32 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$2765.00(+65.35% YoY)

PE Ratio

-

Annual ROE

-177.77%

Annual Debt To Equity

0.07

Beta

1.29

Events Calendar

Earnings

Next earnings date:

Mar 28, 2025

Recent quarterly earnings:

Nov 15, 2024

Recent annual earnings:

Mar 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 7, 2024

Analyst ratings

Recent major analysts updates

Jun 7, 24 Ascendiant Capital
Buy
Mar 31, 23 HC Wainwright & Co.
Buy
Apr 7, 22 HC Wainwright & Co.
Buy
Jul 15, 19 H.C. Wainwright
Buy
May 20, 19 Lake Street
Buy

Screeners with NDRA included

Growing Shares Outstanding
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Diagnostics & Research industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$4.32
NDRA price is $4.32

Price All-time High

$189000.00
NDRA price is currently -100.00% below its historical high of $189000.00

Price Analysts Target

$2625.00
NDRA price is currently -99.84% lower than the consensus analysts' forecast

Price Today Change

-0.92%
NDRA price is down -0.92% today

Price YTD Change

-28.6%
NDRA price is down -28.6% since January 1st

Price 3-Year Change

-99.97%
NDRA price is down -99.97% over the past 3 years

Market cap

Market Cap

$2.32 M
NDRA market capitalization is $2.32 million

Market Cap 3-Year Change

-87.13%
NDRA market capitalization is down -87.13% over the past 3 years

Market Cap All-time High

$115.08 M
NDRA market capitalization is currently -97.98% below its historical high of $115.08 million

Market Cap Sector Rank

6.91%
NDRA market capitalization is higher than 6.91% of companies in Healthcare sector

Technical

Beta

1.29
NDRA beta is 1.29

200-day SMA

$80.35
NDRA price is currently -94.62% below its 200-day simple moving average

14-day RSI

36.23
NDRA 14-day relative strength index is 36.23

30-day Relative Volume

0.60
NDRA 30-day relative volume is 0.60

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
NDRA annual revenue value is unknown

Annual Revenue Analysts Estimate

-
NDRA annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-
NDRA annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
NDRA annual revenue is unknown

Profit

Annual Gross Profit

-
NDRA annual gross profit value is unknown

Annual Gross Margin

-
NDRA annual gross profit margin value is unknown

Annual Operating Profit

-$10.52 M
NDRA annual operating income is -$10.52 million

Annual Operating Margin

-
NDRA annual operating profit margin value is unknown

Annual Net Income

-$10.06 M
NDRA annual net profit is -$10.06 million

Annual Net Margin

-
NDRA annual net profit margin value is unknown

EPS

Annual EPS

-$2765.00
NDRA annual earnings per share is -$2765.00

Annual EPS Analysts Estimate

-$1661.10
NDRA annual earnings per share is currently +66.46% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+65.35%
NDRA annual earnings per share is up +65.35% year-on-year

Annual EPS Sector Rank

0.84%
NDRA annual earnings per share is higher than 0.84% of companies in Healthcare sector

ROA & ROE

Annual ROA

-148.95%
NDRA annual return on assets is -148.95%

Annual ROE

-177.77%
NDRA annual return on equity is -177.77%

EBIT & EBITDA

Annual EBIT

-$10.52 M
NDRA annual earnings before interest & taxes is -$10.52 million

Annual EBITDA

-$10.25 M
NDRA annual EBITDA is -$10.25 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NDRA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NDRA price to earnings ratio is unknown

PB Ratio

PB Ratio

0.35
NDRA price to book ratio is 0.35

PB Ratio Sector Rank

24.07%
NDRA price to book ratio is higher than 24.07% of companies in Healthcare sector

PS Ratio

PS Ratio

-
NDRA price to sales ratio value is unknown

PS Ratio Sector Rank

-
NDRA price to sales ratio is unknown

Enterprise value

Enterprise Value

-$2.19 M
NDRA enterprise value is -$2.19 million

Enterprise Value Sector Rank

8.58%
NDRA enterprise value is higher than 8.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.28
NDRA EV/EBITDA is 0.28

EV/EBITDA Sector Rank

70.77%
NDRA EV/EBITDA is higher than 70.77% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.36
NDRA annual current ratio is 3.36

Annual Quick Ratio

-
NDRA annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.07
NDRA annual debt to equity ratio is 0.07

Annual Interest Coverage Ratio

-
NDRA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NDRA piotroski f-score value is unknown

Altman Z-Score

-
NDRA altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$6.75 M
NDRA annual total assets is $6.75 million

Annual Non Current Assets

$3.72 M
NDRA annual long term assets is $3.72 million

Annual Current Assets

$3.03 M
NDRA annual total current assets is $3.03 million

Annual Cash & Cash Equivalents

$2.83 M
NDRA annual cash & cash equivalents is $2.83 million

Equity

Annual Book Value

$5.66 M
NDRA annual book value is $5.66 million

Annual Working Capital

$2.13 M
NDRA annual working capital is $2.13 million

Liabilities

Annual Total Liabilities

$1.10 M
NDRA annual total liabilities is $1.10 million

Annual Total Long Term Liabilities

$192.10 K
NDRA annual total long term liabilities is $192.10 thousand

Annual Current Liabilities

$903.10 K
NDRA annual total current liabilities is $903.10 thousand

Annual Accounts Payable

$360.40 K
NDRA annual accounts payable is $360.40 thousand

Debt

Annual Total Debt

$394.40 K
NDRA annual total debt is $394.40 thousand

Annual Total Debt 1-Year Change

-27.84%
NDRA annual total debt is down -27.84% year-on-year

Annual Long Term Debt

$192.10 K
NDRA annual long term debt is $192.10 thousand

Annual Short Term Debt

$202.30 K
NDRA annual short term debt is $202.30 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$10.52 M
NDRA annual total expenses is $10.52 million

Annual Operating Expenses

$10.52 M
NDRA annual total operating expenses is $10.52 million

Annual Cost Of Goods Sold

-
NDRA annual cost of goods sold value is unknown

Annual SGA

$5.52 M
NDRA annual SGA is $5.52 million

Annual D&A

$275.50 K
NDRA annual depreciation & amortization is $275.50 thousand

Annual Interest Expense

-
NDRA annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$9.55 M
NDRA annual cash flow from operations is -$9.55 million

Annual CFO 1-Year Change

+25.22%
NDRA annual cash flow from operations is up +25.22% year-on-year

Annual CFI

-$24.70 K
NDRA annual cash flow from investing activities is -$24.70 thousand

Annual CFI 1-Year Change

+87.81%
NDRA annual cash flow from investing activities is up +87.81% year-on-year

Annual CFF

$7.52 M
NDRA annual cash flow from financing activities is $7.52 million

Annual CFF 1-Year Change

-10.49%
NDRA annual cash flow from financing activities is down -10.49% year-on-year

Free CashFlow

Annual FCF

-$9.58 M
NDRA annual free cash flow is -$9.58 million

Annual FCF 1-Year Change

+26.13%
NDRA annual free cash flow is up +26.13% year-on-year

CAPEX

Annual CAPEX

-
NDRA annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
NDRA annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

BDRX logo
Biodexa Pharmaceuticals (BDRX)
ATNF logo
180 Life Sciences (ATNF)
SYRS logo
Syros Pharmaceuticals (SYRS)
AKAN logo
Akanda (AKAN)
THAR logo
Tharimmune (THAR)
SQL logo
SeqLL (SQL)
DRMA logo
Dermata Therapeutics (DRMA)
QLGN logo
Qualigen Therapeutics (QLGN)
YCBD logo
cbdMD (YCBD)

FAQ

  • What is the ticker symbol for ENDRA Life Sciences?
  • Does ENDRA Life Sciences pay dividends?
  • What sector is ENDRA Life Sciences in?
  • What industry is ENDRA Life Sciences in?
  • What country is ENDRA Life Sciences based in?
  • When did ENDRA Life Sciences go public?
  • Is ENDRA Life Sciences in the S&P 500?
  • Is ENDRA Life Sciences in the NASDAQ 100?
  • Is ENDRA Life Sciences in the Dow Jones?
  • When was ENDRA Life Sciences's last earnings report?
  • When does ENDRA Life Sciences report earnings?
  • Should I buy ENDRA Life Sciences stock now?

What is the ticker symbol for ENDRA Life Sciences?

The ticker symbol for ENDRA Life Sciences is NASDAQ:NDRA

Does ENDRA Life Sciences pay dividends?

No, ENDRA Life Sciences does not pay dividends

What sector is ENDRA Life Sciences in?

ENDRA Life Sciences is in the Healthcare sector

What industry is ENDRA Life Sciences in?

ENDRA Life Sciences is in the Diagnostics & Research industry

What country is ENDRA Life Sciences based in?

ENDRA Life Sciences is headquartered in United States

When did ENDRA Life Sciences go public?

ENDRA Life Sciences's initial public offering (IPO) was on June 30, 2017

Is ENDRA Life Sciences in the S&P 500?

No, ENDRA Life Sciences is not included in the S&P 500 index

Is ENDRA Life Sciences in the NASDAQ 100?

No, ENDRA Life Sciences is not included in the NASDAQ 100 index

Is ENDRA Life Sciences in the Dow Jones?

No, ENDRA Life Sciences is not included in the Dow Jones index

When was ENDRA Life Sciences's last earnings report?

ENDRA Life Sciences's most recent earnings report was on Nov 15, 2024

When does ENDRA Life Sciences report earnings?

The next expected earnings date for ENDRA Life Sciences is Mar 28, 2025

Should I buy ENDRA Life Sciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions